MD2722B2 - Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei - Google Patents

Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei

Info

Publication number
MD2722B2
MD2722B2 MDA20020265A MD20020265A MD2722B2 MD 2722 B2 MD2722 B2 MD 2722B2 MD A20020265 A MDA20020265 A MD A20020265A MD 20020265 A MD20020265 A MD 20020265A MD 2722 B2 MD2722 B2 MD 2722B2
Authority
MD
Moldova
Prior art keywords
vitamin
pharmaceutical composition
magnesium
osteoporosis
prophylaxis
Prior art date
Application number
MDA20020265A
Other languages
English (en)
Romanian (ro)
Russian (ru)
Other versions
MD20020265A (en
Inventor
Любослав Разус
Юрай ВЕНДЛ
Иван Варга
Пётр ШИМЕК
Original Assignee
Словакофарма А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Словакофарма А.С. filed Critical Словакофарма А.С.
Publication of MD20020265A publication Critical patent/MD20020265A/xx
Publication of MD2722B2 publication Critical patent/MD2722B2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MDA20020265A 2000-04-06 2001-03-15 Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei MD2722B2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK498-2000A SK284948B6 (sk) 2000-04-06 2000-04-06 Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme
PCT/SK2001/000004 WO2001076610A1 (en) 2000-04-06 2001-03-15 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation

Publications (2)

Publication Number Publication Date
MD20020265A MD20020265A (en) 2003-05-31
MD2722B2 true MD2722B2 (ro) 2005-03-31

Family

ID=20435843

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20020265A MD2722B2 (ro) 2000-04-06 2001-03-15 Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei

Country Status (10)

Country Link
EP (1) EP1274447A1 (pl)
AU (1) AU2001239668A1 (pl)
BG (1) BG107227A (pl)
CZ (1) CZ303069B6 (pl)
EE (1) EE200200584A (pl)
MD (1) MD2722B2 (pl)
PL (1) PL357777A1 (pl)
RU (1) RU2002130196A (pl)
SK (1) SK284948B6 (pl)
WO (1) WO2001076610A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US8383154B2 (en) 2004-05-11 2013-02-26 Egalet A/S Swellable dosage form comprising gellan gum
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
ATE538774T1 (de) * 2009-03-26 2012-01-15 Pulmatrix Inc Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen
MX354829B (es) 2009-03-26 2018-03-22 Pulmatrix Operating Co Inc Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares.
EP2464346A1 (en) 2010-08-30 2012-06-20 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
CN107096014B (zh) 2010-09-29 2022-07-15 普马特里克斯营业公司 吸入用单价金属阳离子干粉剂
CN104487075A (zh) 2012-02-29 2015-04-01 普马特里克斯公司 可吸入干粉剂
CN105324106A (zh) 2013-04-01 2016-02-10 普马特里克斯营业公司 噻托铵干粉
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
RU2726438C2 (ru) * 2018-11-14 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Способ получения сухой высокобелковой молочной смеси для профилактики остеопении у детей и подростков с целиакией
CN109453126A (zh) * 2018-12-07 2019-03-12 浙江核力欣健药业有限公司 一种碳酸钙d3咀嚼片的组合物及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587399A (en) * 1992-12-23 1996-12-24 Abbott Laboratories Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
WO1999047122A1 (en) * 1998-03-16 1999-09-23 Smtm Group, Llc Chewable calcium supplement and method for making it

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587399A (en) * 1992-12-23 1996-12-24 Abbott Laboratories Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
WO1999047122A1 (en) * 1998-03-16 1999-09-23 Smtm Group, Llc Chewable calcium supplement and method for making it

Also Published As

Publication number Publication date
AU2001239668A1 (en) 2001-10-23
PL357777A1 (pl) 2004-07-26
EP1274447A1 (en) 2003-01-15
MD20020265A (en) 2003-05-31
BG107227A (en) 2003-05-30
WO2001076610A1 (en) 2001-10-18
SK4982000A3 (en) 2001-10-08
RU2002130196A (ru) 2004-03-27
SK284948B6 (sk) 2006-03-02
CZ303069B6 (cs) 2012-03-21
EE200200584A (et) 2004-04-15

Similar Documents

Publication Publication Date Title
ES2202601T5 (es) Mejora del sabor de sustancias activas de medicamentos
MD2722B2 (ro) Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
MY118371A (en) Tetrahydrolipstatin containing compositions
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
US3590117A (en) Long-lasting troche containing guar gum
IE48879B1 (en) An analgesic effervescent powder and process for its preparation
US3632778A (en) Tablets containing l-dopa
ZA200301007B (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations.
US5922351A (en) Lubricants for use in tabletting
HUP0004363A2 (hu) Miltefosint tartalmazó orális szilárd gyógyszerkészítmények leishmaniasis kezelésére
JP6580414B2 (ja) 生薬末含有錠剤
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
JP2001097856A (ja) 鎮咳剤
KR20010052819A (ko) 사이클로포스파미드 제피 정제
US2967131A (en) Therapeutic composition
CA1119517A (en) Oral formulations for human use
JP4899304B2 (ja) 塩酸アンブロキソール含有内服用固形製剤
EP0272393A3 (en) Pharmaceutical combination
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
TW561057B (en) Orally rapidly disintegrable tablet capabling of reducing the bitterness
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
US20040005366A1 (en) Healthy bone formulation
GB2336999A (en) High-dosage triclosan compositions
KR900701284A (ko) 미분된 콜레스티폴 하이드로클로라이드